Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 400.000K	--
--	2024/Q4	-- / 936.260K	--
Nov 14, 2024	2024/Q3	214.000K / 1.328M	--
Aug 6, 2024	2024/Q2	1.104M / 1.100M	--
May 9, 2024	2024/Q1	582.000K / 632.600K	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 400.000K--

--2024/Q4-- / 936.260K--

Nov 14, 20242024/Q3214.000K / 1.328M--

Aug 6, 20242024/Q21.104M / 1.100M--

May 9, 20242024/Q1582.000K / 632.600K--

Unlock Free Earnings Estimates

Open Account

BioXcel Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 14, 2024 09:17 ET

BioXcel Therapeutics | 8-K: BioXcel Therapeutics Reports Third Quarter 2024 Financial Results

Nov 14, 2024 07:07 ET

BioXcel Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 6, 2024 09:08 ET

BioXcel Therapeutics | 8-K: BioXcel Therapeutics Reports Second Quarter 2024 Financial Results

Aug 6, 2024 07:08 ET

Symbol Mini Chart % Chg

Unlock the Full List

Analysis

Updated: Jan 23, 2025

Underper form

No Data